PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jmedgeneJournal of Medical GeneticsVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
 
J Med Genet. 1998 August; 35(8): 646–649.
PMCID: PMC1051389

Reassessment of biochemically determined Hunter syndrome carrier status by DNA testing.

Abstract

Deficiency of iduronate-2-sulphatase (IDS) results in the X linked recessive lysosomal storage disorder Hunter syndrome. Determination of carrier status in families affected by this disorder has been performed using a variety of enzymatic tests. None of these tests has proved to be 100% effective at identifying carriers. The aim of this study was to perform carrier testing in a family affected by the disorder, where testing was complicated by the fact that no surviving affected subjects were available for study. Direct dye primer sequencing of PCR products was used to identify mixed bases in an obligate carrier. Two mixed bases were observed within exon VIII. The first base change (T-->A) at nucleotide position 1150 results in a missense mutation (H342Q), while the second base change (G-->T) at nucleotide position 1151 results in a nonsense mutation (G343X). Four additional female family members were screened for the same mutation. Using this approach it is possible to provide unambiguous information about a subject's carrier status and, unlike biochemical testing, this approach will be equally effective when applied to families with the mild form of this disorder.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (915K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Wilson PJ, Morris CP, Anson DS, Occhiodoro T, Bielicki J, Clements PR, Hopwood JJ. Hunter syndrome: isolation of an iduronate-2-sulfatase cDNA clone and analysis of patient DNA. Proc Natl Acad Sci U S A. 1990 Nov;87(21):8531–8535. [PubMed]
  • Flomen RH, Green EP, Green PM, Bentley DR, Giannelli F. Determination of the organisation of coding sequences within the iduronate sulphate sulphatase (IDS) gene. Hum Mol Genet. 1993 Jan;2(1):5–10. [PubMed]
  • Timms KM, Lu F, Shen Y, Pierson CA, Muzny DM, Gu Y, Nelson DL, Gibbs RA. 130 kb of DNA sequence reveals two new genes and a regional duplication distal to the human iduronate-2-sulfate sulfatase locus. Genome Res. 1995 Aug;5(1):71–78. [PubMed]
  • Hopwood JJ, Bunge S, Morris CP, Wilson PJ, Steglich C, Beck M, Schwinger E, Gal A. Molecular basis of mucopolysaccharidosis type II: mutations in the iduronate-2-sulphatase gene. Hum Mutat. 1993;2(6):435–442. [PubMed]
  • Rathmann M, Bunge S, Beck M, Kresse H, Tylki-Szymanska A, Gal A. Mucopolysaccharidosis type II (Hunter syndrome): mutation "hot spots" in the iduronate-2-sulfatase gene. Am J Hum Genet. 1996 Dec;59(6):1202–1209. [PubMed]
  • Archer IM, Harper PS, Wusteman FS. An improved assay for iduronate 2-sulphate sulphatase in serum and its use in the detection of carriers of the Hunter syndrome. Clin Chim Acta. 1981 Apr 27;112(1):107–112. [PubMed]
  • Yutaka T, Fluharty AL, Stevens RL, Kihara H. Iduronate sulfatase analysis of hair roots for identification of Hunter syndrome heterozygotes. Am J Hum Genet. 1978 Nov;30(6):575–582. [PubMed]
  • Nwokoro N, Neufeld EF. Detection of hunter heterozygotes by enzymatic analysis of hair roots. Am J Hum Genet. 1979 Jan;31(1):42–49. [PubMed]
  • Danes BS, Bearn AG. Hurler's syndrome: a genetic study of clones in cell culture with particular reference to the Lyon hypothesis. J Exp Med. 1967 Sep 1;126(3):509–522. [PMC free article] [PubMed]
  • Capobianchi MR, Romeo G. Mosaicism for sulfoiduronate sulfatase deficiency in carriers of Hunter's syndrome. Experientia. 1976 Apr 15;32(4):459–460. [PubMed]
  • Migeon BR, Sprenkle JA, Liebaers I, Scott JF, Neufeld EF. X-linked Hunter syndrome: the heterozygous phenotype in cell culture. Am J Hum Genet. 1977 Sep;29(5):448–454. [PubMed]
  • Tønnesen T, Lykkelund C, Güttler F. Diagnosis of Hunter's syndrome carriers; radioactive sulphate incorporation into fibroblasts in the presence or fructose 1-phosphate. Hum Genet. 1982;60(2):167–171. [PubMed]
  • Tønnesen T. The use of fructose 1-phosphate to detect Hunter heterozygotes in fibroblast cultures from high-risk carriers. Hum Genet. 1984;66(2-3):212–216. [PubMed]
  • Timms KM, Huckett LE, Belmont JW, Shapira SK, Gibbs RA. DNA deletion confined to the iduronate-2-sulfatase promoter abolishes IDS gene expression. Hum Mutat. 1998;11(2):121–126. [PubMed]
  • Metzker ML, Lu J, Gibbs RA. Electrophoretically uniform fluorescent dyes for automated DNA sequencing. Science. 1996 Mar 8;271(5254):1420–1422. [PubMed]
  • Ansari-Lari MA, Liu XM, Metzker ML, Rut AR, Gibbs RA. The extent of genetic variation in the CCR5 gene. Nat Genet. 1997 Jul;16(3):221–222. [PubMed]
  • Tønnesen T, Güttler F, Lykkelund C. Reliability of the use of fructose 1-phosphate to detect Hunter cells in fibroblast-cultures of obligate carriers of the Hunter syndrome. Hum Genet. 1983;64(4):371–375. [PubMed]
  • Zlotogora J, Bach G. Heterozygote detection in Hunter syndrome. Am J Med Genet. 1984 Mar;17(3):661–665. [PubMed]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Group